These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 181895)

  • 41. Turkey herpesvirus infection in chickens: induction of lymphoproliferative lesions and characterization of vaccinal immunity against Marek's disease.
    Witter RL; Sharma JM; Offenbecker L
    Avian Dis; 1976; 20(4):676-92. PubMed ID: 186008
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Notes on the mechanism of postvaccination immunity in Marek's disease.
    Yakovleva LS; Mazurenko NP
    Neoplasma; 1977; 24(4):387-94. PubMed ID: 198688
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evaluation the immuno-protective effect of an infectious clone of meq- deleted Marek's disease virus].
    Li Y; Kang M; Su S; Ding J; Cui Z; Zhu H
    Wei Sheng Wu Xue Bao; 2010 Jul; 50(7):942-8. PubMed ID: 20815243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Difference between influences of homologous and heterologous maternal antibodies on response to serotype-2 and serotype-3 Marek's disease vaccines.
    King D; Page D; Schat KA; Calnek BW
    Avian Dis; 1981; 25(1):74-81. PubMed ID: 6268052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduced shedding of Marek's disease virus from feather follicles of bivalent vaccinated chickens.
    Pruthi AK; Gupta RK; Sadana JR
    Indian J Exp Biol; 1987 Jun; 25(6):405-7. PubMed ID: 2831141
    [No Abstract]   [Full Text] [Related]  

  • 46. Efficacy of coarse-spray administration of a reovirus vaccine in young chickens.
    Giambrone JJ; Hathcock TL
    Avian Dis; 1991; 35(1):204-9. PubMed ID: 1851416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Marek's disease in turkeys: lack of protection by vaccination.
    Elmubarak AK; Sharma JM; Witter RL; Sanger VL
    Am J Vet Res; 1982 Apr; 43(4):740-2. PubMed ID: 6280536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of a combination vaccine containing MDV CVI 988 strain and HVT against challenge with very virulent MDV.
    Geerligs HJ; Weststrate MW; Pertile TL; Rodenberg J; Kumar M; Chu S
    Acta Virol; 1999; 43(2-3):198-200. PubMed ID: 10696445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathogenicity of a Marek's disease virus for chickens vaccinated with graded doses of herpesvirus of turkeys.
    Cauchy L; Coudert F; Dambrine G
    Avian Dis; 1979; 23(4):821-30. PubMed ID: 546406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Field safety and efficacy of in ovo administration of HVT + SB-1 bivalent Marek's disease vaccine in commercial broilers.
    Sarma G; Greer W; Gildersleeve RP; Murray DL; Miles AM
    Avian Dis; 1995; 39(2):211-7. PubMed ID: 7677641
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The epizootologic effectiveness of Deptavac-HVT vaccine against Marek's disease in growing parents].
    Nikolova M; Dzhankov I; Stoĭkov D; Penev P; Stefanov V
    Vet Med Nauki; 1975; 12(7):8-14. PubMed ID: 1179641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytokine gene expression patterns associated with immunization against Marek's disease in chickens.
    Abdul-Careem MF; Hunter BD; Parvizi P; Haghighi HR; Thanthrige-Don N; Sharif S
    Vaccine; 2007 Jan; 25(3):424-32. PubMed ID: 17070626
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies on the pathology of Marek's disease following challenge in chicks vaccinated with three different vaccines.
    Pruthi AK; Gupta RK; Sadana JR
    J Comp Pathol; 1989 Oct; 101(3):295-305. PubMed ID: 2555401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Dynamics and causes of mortality in poultry in the Pleven district].
    Kostakev A; Danchev P
    Vet Med Nauki; 1975; 12(9):28-36. PubMed ID: 1210009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Humoral immune responses to inactivated oil-emulsified Marek's disease vaccine.
    Lee LF; Witter RL
    Avian Dis; 1991; 35(3):452-9. PubMed ID: 1659363
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of infectious bursal disease virus on protection against Marek's disease by turkey herpesvirus vaccine.
    Sharma JM
    Avian Dis; 1984; 28(3):629-40. PubMed ID: 6091603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Derivation, safety and efficacy of a Marek's disease vaccine developed from an Australian isolate of very virulent Marek's disease virus.
    Karpathy RC; Firth GA; Tannock GA
    Aust Vet J; 2002; 80(1-2):61-6. PubMed ID: 12180882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of B-haplotype on the relative efficacy of Marek's disease vaccines of different serotypes.
    Bacon LD; Witter RL
    Avian Dis; 1993; 37(1):53-9. PubMed ID: 8383961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Isolation of an avirulent strain of the chicken herpes virus type B].
    Kasabov R; Nam LV
    Vet Med Nauki; 1982; 19(7):81-8. PubMed ID: 7157664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronological study of cytokine transcription in the spleen and lung of chickens after vaccination with serotype 1 Marek's disease vaccines.
    Gimeno IM; Cortes AL
    Vaccine; 2011 Feb; 29(8):1583-94. PubMed ID: 21215344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.